As research continues, those involved say this would be a game changer, especially for patients with very limited options.
Greg Jicha, M.D., Ph.D., a neurologist and director of clinical trials at UK’s Sanders-Brown Center on Aging, is involved in the National Institutes of Health-funded and Food and Drug ...